BCL6B and hepatocellular carcinoma: Re-expression of BCL6B in gastric cancer, hepatocellular carcinoma, and colorectal cancer cell lines can inhibit colony formation, suppress cell viability, induce apoptosis, and restrain their tumorigenicity in nude mice [27–29].